Search This Blog

Thursday, August 8, 2019

Aimmune Therapeutics EPS misses by $0.08

Aimmune Therapeutics (NASDAQ:AIMT): Q2 GAAP EPS of -$1.01 misses by $0.08.
Cash and equivalents of $72.56M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)